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Streptococcus pyogenesa b s t r a c t
Streptococcus pyogenes employs an IgG speciﬁc endopeptidase, IdeS, to counteract the effector func-
tions of speciﬁc IgG. The physiological signiﬁcant step in disarming speciﬁc IgG is the cleavage of one
IgG heavy chain. So far, characterizations of IdeS enzymatic activity have employed techniques that
failed to differentiate between the ﬁrst and the second cleavage step. The present data demonstrate
that IdeS is active as a monomer and that IdeS activity follows classical Michaelis–Menten kinetics
arguing against the previously proposed formation of a functional IdeS dimer. Our results show that
IdeS inactivates IgG 100-fold faster than previously reported.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Streptococcus pyogenes is the causative agent of a variety of dis-
eases ranging from relatively uncomplicated conditions e.g. phar-
yngitis, to severe invasive conditions, e.g. necrotizing fasciitis [1].
A common mechanism to avoid recognition by speciﬁc, opsonizing
antibodies is the degradation of immunoglobulins (Igs) by Ig-pro-
teases. S. pyogenes employs a highly speciﬁc IgG degrading enzyme
for this purpose; the IgG degrading enzyme of S. pyogenes, IdeS
(sometimes designated Mac1; [2,3]). Immunoglobulin cleavage
by streptococcal IdeS is a sequential process, in which single
cleaved IgG (scIgG) is generated as an intermediate product prior
to the cleavage of the second heavy chain (Fig. 2 [4,5]). Complete
cleavage of both heavy chains separates the antigen binding do-
main of IgG from its effector functions and efﬁciently prevents sig-
naling to immune effector cells [2]. However, already the
proteolytic cleavage of one IgG heavy chain destroys IgG mediator
functions [5] in that scIgG has lost its ability to activate comple-
ment and to interact with Fcc-receptors [5,6]. Nevertheless, earlier
characterizations of IdeS activity employed techniques that either
only detected cleavage of the second IgG heavy chain or that could
not differentiate between ﬁrst and second cleavage e.g. SurfacePlasmon Resonance (SPR) [7,8] size exclusion chromatography
(SEC) [9] reducing SDS–PAGE [2] G-protein coupled SELDI-ToF
[10] or isothermal titration calorimetry [11]. Thus, to date a reli-
able determination on the rate by which IdeS inactivates IgG effec-
tor functions, i.e. the rate by which IdeS generates scIgG, is lacking.
Previous analyses of IdeS enzymatic activity also revealed a
non-Michaelis–Menten velocity curve which has been interpreted
as indication for the presence of two cooperative binding sites
[9,11]. Presence of a substrate binding site, distinct from the cata-
lytic active site, has been suggested for correct positioning of sub-
strate IgG [9]. As an alternative to cooperative binding sites on an
IdeS monomer, a symmetric dimer has been reported for crystal
forms of IdeS [12] and dimerization of IdeS was proposed as an
explanation for the observed non-Michaelis–Menten shaped veloc-
ity curve and as the possible mechanism how IdeS acquires its pro-
nounced speciﬁcity [12].
Despite their essential function only few data on the enzymatic
efﬁciency of Ig-proteases are available ([7,9] for IdeS; [13] for Gin-
gipain K). In this study, IdeS enzymatic activity of the physiologi-
cally important ﬁrst heavy chain cleavage was investigated in
relation to the proposed dimerization of IdeS. The enzyme kinetic
parameters for single and double chain cleavage were determined
and it is demonstrated that IdeS enzyme activity follows classical
Michaelis–Menten kinetics, both regarding ﬁrst and the second
chain cleavage, and that IdeS is active as a monomer.
Fig. 1. Detection of IdeS speciﬁc antibodies. (A) Western blot analysis of IdeS using
polyclonal human IgG as primary antibody. (B) Comparison of IgG and IgG depleted
of IdeS-speciﬁc antibodies (IgG-depl.) as substrates for IdeS. IdeS was incubated
with either IgG (lane 1) or IgG-depl. (lane 2). IdeS speciﬁc antibodies prevent
cleavage of IgG, while IgG-depl. is cleaved by IdeS.
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Puriﬁcation of IdeS: IdeS was expressed and puriﬁed as previ-
ously described [8].
IgG substrate preparation: For afﬁnity puriﬁcation of polyclonal
IgG, enzymatically inactive mutant protein IdeSC94S carrying a
His-Trx tag was covalently coupled to CNBr-activated Sepharose
(GE Biosciences) according to manufacturer’s instructions and
washed with 0.1 M Tris–HCl, 500 mM NaCl at pH 6.8 and pH 8.8
[9]. The ﬁnal concentration of covalently coupled protein was
6 mg per ml of Sepharose. IgG (190 mg), (Sigma) was applied to a
PD10 column and eluted with assay buffer (20 mM phosphate buf-
fer; pH 6.5; I = 154 mM adjusted with NaCl). IgG was incubated
with 1 ml IdeSC94S-Sepharose at room temperature and the ﬂow-
through was collected and incubated again with 1 ml IdeSC94S-Se-
pharose. The procedure was repeated twice with incubation times
of 6–12 h for all incubations. The ﬂow-through from the last incu-
bation consists of afﬁnity puriﬁed IgG lacking IdeS speciﬁc antibod-
ies (IgG-depl.) For western blot analysis 4 lg, 1 lg, 0.25 lg and
0.0625 lg of IdeS were run on a denaturing, reducing 12% SDS–
PAGE. Western blots were performed using standard techniques
using 5% dry milk in PBS + 0.05% Tween-20 as blocking buffer.
Commercial polyclonal IgG (0.1 mg/ml) was used as primary anti-
body and Goat anti-human HRP conjugate (BioRad) as secondary
antibody. For ELISA analyses enzymatically inactive mutant pro-
tein IdeSC94S at a protein concentration of 0.1–10 lg/ml was coated
on a Maxisorp plate (Nunc) in 50 mM carbonate buffer pH 9.6.
0.05% Tween-20 in PBS was used as washing buffer and 2% BSA
was used as blocking reagent. IgG or IgG-depl. were used as pri-
mary antibody at a concentration of 0.1–100 lg/ml. Goat anti-hu-
man HRP conjugate (BioRad) (1/2000) was used as secondary
antibody. HRP substrate kit (BioRad) was used for detection and
a Tecan Inﬁnite M200 instrument was used for quantiﬁcation.
Endopeptidase assays: To determine the kinetics of IdeS, 2 nM
IdeS (256 nM for the detection of the second cleavage) was mixed
with 1.67–200 lM IgG-depl. and incubated at 37 C. Each reaction
was sampled at multiple time points and stopped by incubation at
96 C in pre-warmed non-reducing loading buffer. Buffer was assay
buffer with 1.25 lM BSA added. Samples were analyzed by 8%
SDS–PAGE under non-reducing conditions. Gels were stained with
Coomassie Fluor Orange (Invitrogen). The rate of reaction was
determined by densitometrically quantifying the bands. Bands cor-
responding to IgG and scIgG were used to determine the rate of
ﬁrst cleavage, and bands corresponding to scIgG and F(ab0)2 were
used to determine the rate of second cleavage. Band intensities
were quantiﬁed using the LAS4000 imaging system and Multi
Gauge Software (Fujiﬁlm, Version 3.2). Kinetic constants were cal-
culated using GraphPad Prism non-linear regression tools. All
experiments were done at least twice with duplicate samples
(n = 4). To determine the effect of neutralizing antibodies on IdeS
activity, 66.6 lM IgG were incubated with 5–1280 lM IdeS at
37 C and reactions were sampled between 5 and 160 min and ana-
lyzed as described above. For determination of speciﬁc activity
dependency on enzyme concentration, IgG-depl. at a concentration
of 66.6 lM was incubated with 0.5–32 nM IdeS and analyzed as
described above.
Dynamic light scattering measurements: Recombinant IdeS in PBS
at 180 lM and 18 lM was analyzed by dynamic light scattering
(DLS) (Nano Zetasizer equipped with a HeNe-laser with a wave
length of 633 nm, Malvern Instruments). 50 ll of sample was mea-
sured at room temperature for 480 s and back scatter was detected
at an angle of 173. The DLS data was analyzed using the Disper-
sion Technology Software v.5.10 (Malvern).
Size exclusion chromatography: Recombinant IdeS at 1 mM
(1 ml; 37.29 mg/ml) was applied to a HiPrep 16/60 SephacrylS-100 HR column (GE Biosciences) controlled by an FPLC system
(ÄktaPrime plus, GE Biosciences). Separation was carried out at a
ﬂow rate of 0.5 ml/min at room temperature. Fractions of the iso-
lated ﬁrst and second peak were pooled and concentrated to 1 ml
giving concentrations of 1.04 and 12.81 mg/ml respectively and
once more subjected to SEC analysis. Peak fractions were analyzed
by SDS–PAGE on 16% Novex Tricine gels (Invitrogen) under reduc-
ing conditions. Bands of the ﬁrst peak sample migrating between
27 and 15 kDa were subjected to MALDI-TOF mass spectroscopy
at the Umeå Protein Analysis Facility, Umeå University.
To assess endopeptidase activity in peak fractions, protein from
both peaks (10 ll; 0.05 mg/ml in assay buffer) was incubated with
human IgG1 (10 ll) (Sigma) at 8.07 lM in 20 mM Tris-buffered sal-
ine pH 8.0 for 5 min at 37 C and reactions were terminated with
iodoacetamide (10 ll, 16.5 mM) (Sigma). Approximately 2 lg pro-
tein from each reaction was subjected to 8% or 10% SDS–PAGE un-
der denaturing, non-reducing conditions and stained with
Coomassie blue.
3. Results
Substrate IgG preparation: Antibodies against IdeS have been
found in serum samples of healthy blood donors, as well as in sam-
ples from patients with mild or invasive streptococcal disease
[3,14–16]. Speciﬁc antibodies are also present in commercial
sources of polyclonal IgG as determined by Western blot
(Fig. 1A) and ELISA (data not shown). Commercial IgG preparations
at physiological concentrations were found to completely inhibit
20 nM of IdeS, and signiﬁcant inhibition of up to 80 nM of IdeS
could be detected (data not shown). Due to these relatively high
concentrations of neutralizing antibodies it is likely that IdeS anti-
bodies interfered with earlier characterizations of IdeS0 IgG cleav-
ing properties [9,10]. For appropriate determination of IdeS
kinetics, speciﬁc IdeS antibodies were depleted from IgG prepara-
tions by antigen afﬁnity chromatography using the enzymatically
inactive IdeSC94S protein as antigen. Afﬁnity puriﬁed IgG showed
Fig. 2. Time course of IgG cleavage by IdeS. (A) IgG1 was cleaved by IdeS and
proportions of intact IgG, scIgG and F(ab0)2 were analyzed by SDS–PAGE. Most IgG is
converted to scIgG prior to second chain cleavage. (B) Schematic representation of
sequential IgG cleavage by IdeS. scIgG, single cleaved IgG; Fc, receptor binding
domain; F(ab0)2, antigen binding domain.
1820 R. Vindebro et al. / FEBS Letters 587 (2013) 1818–1822no inhibitory capacity towards IdeS (Fig. 1B) and was used as sub-
strate in subsequent experiments.
Determination of heavy chain cleavage by IdeS: First and second
chain cleavage steps were detected by denaturing, non-reducing
SDS–PAGE that allows for the separation of IgG, scIgG, F(ab0)2
and ½Fc fragments (Fig. 2 and [4]). Densitometric measurements
of the SDS–PAGE gels were used to measure ratio of substrate/
product at each time point. The rate of the reaction was calculated
as the number of substrate molecules cleaved per second per IdeS
molecule. The obtained velocity curves for ﬁrst and second chain
cleavage show typical Michaelis–Menten kinetics (Fig. 3). Kinetic
analyses give a Km value of 7.2 lM and a kcat value of 10.1 s1 for
ﬁrst single chain cleavage and a Km value of 28 lM and a kcat value
of 0.10 s1 for second chain cleavage (Fig. 3 and inset). Thus, the
kcat for single chain cleavage of IgG, which represents the rate by
which IgG becomes immunologically inactivated, is approximately
100 fold higher at Vmax compared to values obtained for complete
cleavage of IgG. When monitoring product formation over time,
basically all IgG is converted to scIgG before second chain cleavageFig. 3. Enzyme kinetics of ﬁrst chain cleavage. Varying concentrations of IgG-depl.
were incubated with IdeS and reactions were sampled continuously. The rate of
reaction was determined by quantifying bands corresponding to substrate (IgG) and
product (scIgG). Inset: Kinetics of second chain cleavage of IgG. Diamonds
correspond to measured rates, solid lines correspond to an ideal Michaelis–Menten
curve. The rate of reaction was determined by densitometrically quantifying the
bands.is detectable (Fig. 2 and [4]), demonstrating that the proposed
simultaneous cleavage of both IgG heavy chains is not a relevant
functional mechanism [12].
IdeS is active as a monomeric enzyme in solution: Previous analy-
ses of IdeS enzyme kinetics demonstrated an aberrant, sigmoidal
shaped velocity curve [9,11]. It has been suggested that IdeS has
multiple binding sites or functions as a dimeric enzyme
[9,12,17]. However, the current results for the formation of scIgG
or complete cleavage of IgG by IdeS show no indication of an aber-
rant velocity curve, but instead demonstrate that IdeS kinetics fol-
lows a classical hyperbolic saturation curve typical for Michaelis–
Menten kinetics (Fig. 3). Consequently, an enzyme kinetic argu-
ment for cooperativity is not evident from these results. Assuming
that IdeS is active as a dimer, the proportion of the active dimer
complex should be dependent on enzyme concentration [18,19]
and therefore the speciﬁc activity should increase as a function
of enzyme concentration [18,19]. However, when monitoring en-
zyme activity as a function of enzyme concentration the speciﬁc
activity of IdeS proved independent from enzyme concentration
(Fig. 4), indicating that dimer formation is not a prerequisite for
IdeS activity. This view is supported by the ﬁnding that covalently
immobilized IdeS, which is prevented from oligomerisation, also
exhibits efﬁcient IgG cleavage [20] (data not shown).
A KD for IdeS dimerization has been determined in the lM range
for immobilized IdeS [11,12]. IdeS stoichiometry in solution was
investigated by dynamic light scattering (DLS). DLS measures the
size of proteins in solution by determining the velocity of Brown-
ian motions. IdeS at 18 and 180 lM was analyzed and the size of
IdeS in solution was estimated to approximately 37 kDa with only
one single peak detected at both concentrations (Fig. 5). Based on
these data we conclude that only monomeric IdeS is present in
solution and that formation of a dimeric protein cannot be
conﬁrmed.
Size exclusion chromatography: The results from DLS analyses are
in contrast to previous data from SEC experiments describing the
presence of monomeric and dimeric forms of IdeS in solution
[12]. IdeS at a concentration of 1 mM was applied to SEC chroma-
tography. The protein eluted in two peaks as previously reported
(Fig. 6A, top panel, [12]), but when isolated peak fractions were
concentrated to original volume and reloaded on the SEC column,
no equilibrium between the potential dimeric and monomeric
forms of the enzyme was detected; instead two stable protein
peaks were evident (Fig. 6A, mid and bottom panel). Fractions from
the ﬁrst peak contained several smaller protein bands on SDS–Fig. 4. Determination of speciﬁc activity dependency on enzyme concentration.
Constant amounts of IgG-depl. were incubated with increasing amounts of IdeS. The
speciﬁc activity of IdeS is independent from enzyme concentration.
Fig. 5. Size determination of IdeS in solution. The size of IdeS, at 180 and 18 lM, in
solution was analyzed using dynamic light scattering (DLS). IdeS in solution is
detected as a 37 kDa protein.
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spectrometry as truncated IdeS. Degradation products of IdeS
should, due to their smaller size, elute after full length IdeS onFig. 6. Analysis of IdeS stoichiometry by size exclusion chromatography (SEC). (A) SEC elu
to avoid cross-contamination between peaks and collected fractions were pooled, re-con
PAGE. Lane 1, fraction collected from the ﬁrst peak; lane 2, fraction collected from the se
degradation was analyzed under non-reducing conditions by SDS–PAGE.SEC, but since these products are present in sample fractions corre-
sponding to the ﬁrst peak, it appears that these proteins aggregate
in complex with misfolded protein and minor amounts of active
enzyme, creating higher molecular weight particles. If this hypoth-
esis is correct, then the speciﬁc enzymatic activity of these frac-
tions should be considerably lower compared to fractions derived
from monomeric IdeS. Enzymatic activity in peak fractions was
analyzed and conﬁrmed that protein samples from the monomer
peak contained high IgG cleaving activity converting all IgG sub-
strate into ½Fc and F(ab0)2 fragments at the time point analyzed
(Fig. 6C, lane 3), while identical amounts of protein from the puta-
tive dimer-peak exhibited much lower activity with most IgG still
in the scIgG form (Fig. 6C, lane 2). We conclude that the ﬁrst peak
eluting in SEC does not contain dimeric IdeS, but rather represents
partially degraded – possibly misfolded protein – in complex with
minor amounts of active protein and that the dimeric form of IdeS
does not represent the enzymatically active state of the protein.4. Discussion
IgG antibodies represent a substantial threat to invading bacte-
ria. The human pathogen S. pyogenes employs a highly speciﬁc IgG
endopeptidase, IdeS, for this purpose [2,3].tion proﬁle of recombinant IdeS. Fractions of the ﬁrst and second peak were chosen
centrated and reloaded on the same column. (B) Protein content analyzed by SDS–
cond peak. (C) Endopeptidase activity of IdeS collected from SEC fractionation. IgG1
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sequential manner, generating scIgG molecules [4] lacking effector
functions [5]. A renewed analysis of IdeS kinetics, measuring the
generation of scIgG, shows that IdeS cleaves IgG at a signiﬁcantly
faster rate than previously reported. A 40–100 fold (Fig. 2 [7,11])
increased kcat value for ﬁrst single chain cleavage deﬁnes IdeS as
an even more efﬁcient IgG endopeptidase and adds to the view that
IgG hydrolysis by IdeS signiﬁcantly contributes to streptococcal
virulence. ScIgG binds only poorly to Fcc receptors, most likely
due to the disruption of key structural factors in the hinge domain
[5], which also might explain the observed differences between IgG
and scIgG as a substrate for IdeS.
Although IgG effector functions are efﬁciently inhibited after
single chain cleavage, second chain cleavage, although slow, is still
important for streptococcal pathogenesis. ½Fc fragments, prime
neutrophil ROS production, leading to an earlier and more power-
ful response after activation by immunocomplexes [20]. Therefore,
IgG cleavage can be regarded as a two-step process, where cleav-
age of the ﬁrst heavy chain of IgG inactivates IgG effector functions
and cleavage of the second heavy chain generates ½Fc fragments
that can prime and affect neutrophils.
Previous studies addressed IdeS enzymatic properties and mea-
sured proteolysis of IgG heavy chains [7,9,11]. Results from those
analyses presented a sigmoidal shaped velocity curve and were
interpreted as cooperativity [7,9,11] that could be achieved either
by the presence of two separated substrate recognition motifs on
one enzyme monomer or by a dimeric enzyme as the catalytically
active form of IdeS [9,12].
Dimer formation has also been proposed as an explanation for
the pronounced substrate speciﬁcity of IdeS [12]. Although an
attractive theory on the mechanism, the data of the current study
demonstrate a sequential cleavage of IgG by active IdeS monomers
and do not support the hypothesis of dimer formation. Notably,
scIgG generation by IdeS follows a classical Michaelis–Menten sat-
uration curve, and does not support the notion of cooperative bind-
ing sites. Therefore, dimer formation cannot be a prerequisite for
enzymatic activity and in fact no evidence for functional dimers
was found (Figs. 2, 4 and 5). Previous mutational studies assigned
potential interface residue F129 as important for dimer formation,
but in absence of a functional dimer, we suggest that this residue,
although important for enzymatic activity, most likely affects the
structural integrity of IdeS, which is supported by the ﬁnding that
mutations in this residue strongly affected the solubility of the en-
zyme [12]. Putative dimer forms of IdeS have not been observed
when IdeS was ﬁrst crystallized at 1.9 Å resolution [21] and in sil-
ico analyses of available crystals (PDB codes 2AU1, 2AVW and
1Y08) using PISA CSS and DiMoVo algorithms [22,23] indicate that
IdeS dimer crystals might rather be a result of crystal packaging
[24] (http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html; last
accession 2012-11-12).
In summary, we demonstrate that IdeS, the IgG endopeptidase
of S. pyogenes, exhibits a considerable faster proteolytic activity to-
wards its sole substrate IgG than previously reported. The newly
determined kcat value of 10.1 s1 makes it feasible that the enzyme
actively contributes to the defense of S. pyogenes against speciﬁc
antibodies and underlines the importance of the IgG protease. In
addition, we also demonstrate that the protease is active in its
monomeric form.
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